Back to News
Market Impact: 0.55

Truist Securities reiterates Buy rating on Couchbase stock

BASEGSMS
Analyst InsightsCorporate EarningsCorporate Guidance & OutlookCompany FundamentalsTechnology & InnovationArtificial Intelligence
Truist Securities reiterates Buy rating on Couchbase stock

Couchbase (BASE) reported strong Q1 fiscal year 2026 results, exceeding guidance and prompting Truist Securities to reaffirm its Buy rating with a $21 price target. The company's ARR reached $252.1 million, with revenue up 10% year-over-year, leading to an increased full-year ARR growth forecast of over 18%; however, the company's EPS missed estimates. Despite positive ratings from DA Davidson and Stifel, Goldman Sachs reiterated a Sell rating, citing concerns about profitability, reflecting mixed sentiment despite the improved outlook.

Analysis

Couchbase Inc. (NASDAQ:BASE) reported first-quarter fiscal year 2026 results that surpassed its own guidance, leading Truist Securities to reaffirm its Buy rating and $21.00 price target. The company achieved annual recurring revenue (ARR) of $252.1 million, with quarterly revenue increasing 10% year-over-year, and revenue growth over the last twelve months standing at 16.35%. Gross profit margins remain impressive at 88%. Management indicated a recovery from fiscal year 2025 challenges, citing stability from large customer growth and strong momentum in its Capella offering, which underpins an increased full-year ARR growth forecast to over 18%. Despite this top-line strength, which saw revenue exceed projections by $910,000, earnings per share (EPS) of -0.33 missed the forecasted -0.08. Couchbase conservatively adjusted its full-year ARR and revenue forecasts upwards, a cautious stance supported by Truist given macroeconomic uncertainties and previous quarterly challenges. Analyst sentiment is mixed: DA Davidson (PT $25.00) and Stifel (PT $22.00) maintained Buy ratings, and Morgan Stanley raised its target to $19, citing 20% ARR growth in constant currency. However, Goldman Sachs reiterated a Sell rating with a $16 price target, expressing concerns over the company's path to positive operating margins and free cash flow. The stock currently trades at $18.56, which InvestingPro data suggests is slightly above its Fair Value, while analyst targets range from $16 to $26.

AllMind AI Terminal